Cardiol Therapeutics Inc Class A (CRDL : TSX)
Common Stock
$2.58
CAD
+0.00 (%)
Last updated: 2026-08-24
Get CRDL alerts:
CRDL
Cardiol Therapeutics Inc Class A
WealthAwesomePerformance
1 Day
+0.00%
1 Week
+3.61%
1 Month
+54.49%
YTD
+89.71%
Key Statistics
Market Cap
$301.40M
52W High
$2.75
52W Low
$1.23
P/E Ratio
-
50 Day MA
$1.77
200 Day MA
$1.60
Beta
0.47
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 8/24/2026 | $2.56 | $2.59 | $2.44 | $2.58 | $2.58 | 212,966 |
| 8/21/2026 | $2.63 | $2.63 | $2.56 | $2.58 | $2.58 | 144,867 |
| 8/20/2026 | $2.69 | $2.75 | $2.53 | $2.61 | $2.61 | 338,579 |
| 8/19/2026 | $2.65 | $2.70 | $2.57 | $2.70 | $2.70 | 290,574 |
| 8/18/2026 | $2.52 | $2.63 | $2.42 | $2.61 | $2.61 | 218,837 |
| 8/17/2026 | $2.47 | $2.69 | $2.45 | $2.49 | $2.49 | 351,870 |
| 8/14/2026 | $2.35 | $2.53 | $2.29 | $2.51 | $2.51 | 407,983 |
| 8/13/2026 | $2.12 | $2.45 | $2.09 | $2.42 | $2.42 | 360,761 |
| 8/12/2026 | $2.10 | $2.12 | $2.00 | $2.12 | $2.12 | 236,800 |
| 8/11/2026 | $2.07 | $2.12 | $2.02 | $2.11 | $2.11 | 151,752 |
Analyst Price Targets
Based on analyst covering CRDL
Wall Street analysts forecast CRDL stock price to rise 132.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+132.6% Upside
Current Price
C$2.58
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CRDL's historical volatility
30-Day Vol
69.1%
Annualized
90-Day Vol
59.0%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$3.08
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.74 | C$2.16 – C$3.48 |
| 60 trading days | C$2.91 | C$2.07 – C$4.07 |
| 90 trading days | C$3.08 | C$2.04 – C$4.66 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Cardiol Therapeutics Inc Class A
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-35.85M
- Profit Margin
- 0.00%
- ROE (TTM)
- -190.18%
- EPS (Diluted)
- -0.34
- Book Value
- 0.21
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About CRDL
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
CRDL.TO news timeline
15 articles covering CRDL.TO, most recent first
LatestWhat's Going On With Cardiol Therapeutics Inc Class A Stock Tuesday?
August 2026
- Why Cardiol Therapeutics Inc Class A stock is sliding today
- Why Cardiol Therapeutics Inc Class A stock went up yesterday
- What's Going On With Cardiol Therapeutics Inc Class A Stock Tuesday?
- Cardiol Therapeutics Inc Class A CRDL Earnings Beat Estimates by 50.0%
- Why Cardiol Therapeutics Inc Class A stock is gaining today
- Why Cardiol Therapeutics Inc Class A stock is sliding today
- Cardiol Therapeutics Inc Class A CRDL Earnings Beat Estimates by 50.0%
- Why Cardiol Therapeutics Inc Class A stock is sliding today
- Will Cardiol Therapeutics Inc Class A (CRDL) Beat Estimates Again in Its Next Earnings Report?
- What's Going On With Cardiol Therapeutics Inc Class A Stock Tuesday?
- What's Going On With Cardiol Therapeutics Inc Class A Stock Tuesday?
- Why Cardiol Therapeutics Inc Class A stock is rising today